Soc. Generale Knock-Out BIO/ DE000SU1C8F3 /
19.11.2024 13:38:31 | Изменение-0.08 | Бид14:05:14 | Предложение14:05:14 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
2.19EUR | -3.52% | 2.18 Величина цены спроса: 10,000 |
2.36 Величина цены предложения: 10,000 |
Bio Rad Laboratories... | 190.9265 USD | 31.12.2078 | Call |
GlobeNewswire
12.08
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection i...
GlobeNewswire
24.06
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Lea...
GlobeNewswire
03.06
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
GlobeNewswire
29.03.2022
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital...
GlobeNewswire
22.03.2022
Iridia Announces Appointment of Thomas H. Cauley, Ph.D. as Vice President, Engineering
GlobeNewswire
03.08.2021
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
GlobeNewswire
01.06.2021
RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickso...
GlobeNewswire
24.08.2020
Landec Nominates Three New Members to its Board of Directors, Providing Deep Expertise to Both Busin...
GlobeNewswire
04.05.2020
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
Newsfile Corp
16.04.2020
LexaGene CEO Discusses COVID-19 Testing, Commercialization Strategy -- SECFilings.com
GlobeNewswire
20.03.2020
Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors
Newsfile Corp
09.03.2020
Coronavirus Highlights Need for Rapid Testing of Pathogens -- SECFilings.com
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница